Affordable Access

Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin.

Authors
  • Lazzaroni, M
  • Imbimbo, B P
  • Bargiggia, S
  • Sangaletti, O
  • Dal Bo, L
  • Broccali, G
  • Bianchi Porro, G
Type
Published Article
Journal
Antimicrobial agents and chemotherapy
Publication Date
Oct 01, 1993
Volume
37
Issue
10
Pages
2212–2216
Identifiers
PMID: 8257146
Source
Medline
License
Unknown

Abstract

The present study was designed to determine the effects of an antacid suspension containing magnesium hydroxide and aluminum hydroxide (30 ml of Maalox) on the oral bioavailability of rufloxacin (400 mg). Rufloxacin was administered orally to 12 healthy volunteers according to a randomized, balanced, crossover design. Three treatments were administered to each subject, with a 10-day washout period between treatments; the treatments included rufloxacin alone, rufloxacin taken 5 min after antacid, and rufloxacin taken 4 h before antacid. Administration of antacid within 5 min before the administration of rufloxacin resulted in a substantial decrease in rufloxacin absorption, with a mean percent relative bioavailability compared with control values of 64% (range, 42 to 77%). Administration of antacid 4 h after the administration of rufloxacin slightly affected the absorption of the quinolone (mean relative bioavailability, 87%; range, 51 to 110%). Antacids that contain magnesium and aluminum salts reduce the absorption of rufloxacin. The extent of this interaction depends on the time that elapses between administration of the two drugs.

Report this publication

Statistics

Seen <100 times